title: Menstrual migraines: Which options and when?
abstract: Would your patient benefit from abortive therapy or prophylactic treatment? And which regimen is likely to provide the best--and safest--relief?
authors.affiliation: University of Wisconsin, Department of Family Medicine and Community Health, WI, USA.
authors.forename: Ronni
authors.initials: R
authors.lastname: Hayon
authors.affiliation: University of Wisconsin, Department of Family Medicine and Community Health, WI, USA.
authors.forename: Jensena
authors.initials: J
authors.lastname: Carlson
authors.affiliation: University of Wisconsin, Department of Family Medicine and Community Health, WI, USA.
authors.forename: Julia
authors.initials: J
authors.lastname: McMillen
authors.affiliation: University of Wisconsin, Department of Family Medicine and Community Health, WI, USA. Email: sbschrag@wisc.edu.
authors.forename: Sarina
authors.initials: S
authors.lastname: Schrager
mesh_terms: D000328:Adult; D000700:Analgesics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008598:Menstruation / Q000187:drug effects*; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D017410:Practice Guidelines as Topic; D011293:Premenstrual Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000700:Analgesics